Chapter 1 Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Overview
1.1 Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Definition
1.2 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Size Status and Outlook (2017-2031)
1.3 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Size Comparison by Region (2017-2031)
1.4 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Size Comparison by Type (2017-2031)
1.5 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Size Comparison by Application (2017-2031)
1.6 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Size Comparison by Sales Channel (2017-2031)
1.7 Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Dynamics
1.7.1 Market Drivers/Opportunities
1.7.2 Market Challenges/Risks
1.7.3 Market News (Mergers/Acquisitions/Expansion)
1.7.4 COVID-19 Impacts
1.7.5 Russia-Ukraine War Impacts
Chapter 2 Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Segment Analysis by Player
2.1 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales and Market Share by Player (2020-2022)
2.2 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue and Market Share by Player (2020-2022)
2.3 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Average Price by Player (2020-2022)
2.4 Players Competition Situation & Trends
2.5 Conclusion of Segment by Player
Chapter 3 Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Segment Analysis by Type
3.1 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market by Type
3.1.1 Eluxadoline
3.1.2 Rifaximin
3.1.3 Alosetron
3.1.4 Loperamide
3.1.5 Diphenoxylate + Atropine
3.2 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales and Market Share by Type (2017-2022)
3.3 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue and Market Share by Type (2017-2022)
3.4 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Average Price by Type (2017-2022)
3.5 Leading Players of Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs by Type in 2022
3.6 Conclusion of Segment by Type
Chapter 4 Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Segment Analysis by Application
4.1 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market by Application
4.1.1 Rx
4.1.2 OTC
4.2 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue and Market Share by Application (2017-2022)
4.3 Leading Consumers of Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs by Application in 2022
4.4 Conclusion of Segment by Application
Chapter 5 Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Segment Analysis by Sales Channel
5.1 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market by Sales Channel
5.1.1 Direct Channel
5.1.2 Distribution Channel
5.2 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue and Market Share by Sales Channel (2017-2022)
5.3 Leading Distributors/Dealers of Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs by Sales Channel in 2022
5.4 Conclusion of Segment by Sales Channel
Chapter 6 Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Segment Analysis by Region
6.1 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Size and CAGR by Region (2017-2031)
6.2 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales and Market Share by Region (2017-2022)
6.3 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue and Market Share by Region (2017-2022)
6.4 North America
6.4.1 North America Market by Country
6.4.2 North America Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Share by Type
6.4.3 North America Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Share by Application
6.4.4 United States
6.4.5 Canada
6.4.6 Mexico
6.5 Europe
6.5.1 Europe Market by Country
6.5.2 Europe Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Share by Type
6.5.3 Europe Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Share by Application
6.5.4 Germany
6.5.5 UK
6.5.6 France
6.5.7 Italy
6.5.8 Russia
6.5.9 Spain
6.6 Asia-Pacific
6.6.1 Asia-Pacific Market by Country
6.6.2 Asia-Pacific Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Share by Type
6.6.3 Asia-Pacific Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Share by Application
6.6.4 China
6.6.5 Japan
6.6.6 Korea
6.6.7 India
6.6.8 Southeast Asia
6.6.9 Australia
6.7 South America
6.7.1 South America Market by Country
6.7.2 South America Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Share by Type
6.7.3 South America Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Share by Application
6.7.4 Brazil
6.7.5 Argentina
6.7.6 Colombia
6.8 Middle East & Africa
6.8.1 Middle East & Africa Market by Country
6.8.2 Middle East & Africa Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Share by Type
6.8.3 Middle East & Africa Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Share by Application
6.8.4 UAE
6.8.5 Saudi Arabia
6.8.6 South Africa
6.9 Conclusion of Segment by Region
Chapter 7 Profile of Leading Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Players
7.1 Astellas Pharmaceuticals
7.1.1 Company Snapshot
7.1.2 Product/Service Offered
7.1.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share)
7.2 Actavis
7.3 Pfizer
7.4 GlaxoSmithKline
7.5 Salix Pharmaceuticals
7.6 AstraZenenca
7.7 Ironwood Pharmaceuticals
7.8 Allergan
7.9 Takeda Pharmaceutical
7.10 Sebela Pharmaceuticals
7.11 Synergy Pharmaceuticals
7.12 Synthetic Biologics
7.13 Bausch Health
Chapter 8 Upstream and Downstream Analysis of Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs
8.1 Industrial Chain of Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs
8.2 Upstream of Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs
8.3 Downstream of Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs
Chapter 9 Development Trend of Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs (2023-2031)
9.1 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Size (Sales and Revenue) Forecast (2023-2031)
9.2 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Size and CAGR Forecast by Region (2023-2031)
9.3 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Size and CAGR Forecast by Type (2023-2031)
9.4 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Size and CAGR Forecast by Application (2023-2031)
9.5 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Size and CAGR Forecast by Sales Channel (2023-2031)
Chapter 10 Appendix
10.1 Research Methodology
10.2 Data Sources
10.3 Disclaimer
10.4 Analysts Certification
